由超级增强剂控制的IGLL5会影响成熟B细胞淋巴瘤中的细胞存活率和MYC表达
Hiroki Hosoi1, Shotaro Tabata1, Hideki Kosako1
1Department of Hematology/Oncology, Wakayama Medical University, Wakayama, Japan.
Leukemia research reports
|March 6, 2024
概括
IGLL5基因位于B细胞瘤中超级增强体 (SEs) 附近,在瘤细胞存活中发挥作用. 它的表达受到SEs的调节,并影响MYC的表达,这表明它参与了瘤发生.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- IGLL5基因在B细胞瘤中经常发生突变和转移.
- 它与超级增强剂 (SE) 的接近表明它可能在瘤发生过程中发挥作用.
- 在B细胞恶性瘤中IGLL5的功能意义在很大程度上仍未被探索.
研究的目的:
- 为了研究IGLL5在成熟的B细胞淋巴瘤中的功能作用.
- 确定控制IGLL5表达的监管机制.
- 为了阐明IGLL5和MYC表达在B细胞瘤中的关系.
主要方法:
- 对B细胞淋巴瘤细胞系IGLL5mRNA表达的分析.
- 用JQ1 (一种BET抑制剂) 治疗以评估SE介导调节.
- 淘汰IGLL5以评估其对细胞活力和MYC表达的影响.
主要成果:
- 在成熟的B细胞淋巴瘤细胞系中检测到IGLL5mRNA,利用Cλ1段.
- JQ1治疗导致IGLL5表达减少,证实SE控制.
- IGLL5 knockdown诱导B细胞淋巴瘤细胞死亡和减少MYC表达.
结论:
- IGLL5受SEs的调节,有助于成熟的B细胞瘤的存活.
- IGLL5的表达与MYC的表达有关,这表明它在B细胞瘤发生过程中发挥了作用.
- 向IGLL5可能代表B细胞恶性瘤的新疗法策略.
相关概念视频
Induced Pluripotent Stem Cells
4.1K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.1K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
B Cell Activation and Differentiation
1.7K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.7K
Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K
The Intrinsic Apoptotic Pathway
6.5K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.5K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K


